Tatevik Hovakimyan and Rachel ter Bekke: Modern Insights into Cardiomyopathies and Channelopathies
Tatevik Hovakimyan, Co-Founder and CEO at CardioLab Medical Center, reposted CardioLab.Armenia’s post on LinkedIn:
“Stay tuned for our upcoming webinar at CardioLab Armenia with Rachel M.A. ter Bekke on following topics:
- Modern Perspectives on the Diagnosis and Management of Cardiomyopathies
- Inherited Arrythmia Syndromes: The Science of Cardiac Channelopathies”
Quoting CardioLab.Armenia’s post:
“To update knowledge on arrhythmias and cardiomyopathies and for the purpose of international experience exchange, the “CardioLab” cardiology clinic is organizing a webinar entitled “Beyond The Beat: Modern Insights into Cardiomyopathies and Channelopathies”.
Participation will be free and held online
CME credits are planned
November 26
Time: 15:00 – 17:00
Speakers
-Tatevik Hovakimyan, Yerevan, Armenia
Cardiologist, Arrhythmologist, Public Health Specialist
– Rachel ter Bekke, Maastricht, Netherlands
Cardiologist, Electrophysiologist
Topics
- Modern Perspectives on the Diagnosis and Management of Cardiomyopathies
- Inherited Arrhythmia Syndromes: The Science of Cardiac Channelopathies
Please use the link to register.”
Stay informed with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis